Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

BIBW 2992 (Afatinib) vs Gemcitabine-cisplatin in 1st Line Non-small Cell Lung Cancer (NSCLC)
afatinib
1200.34
NCT01121393
Carcinoma, Non-Small-Cell Lung; Adenocarcinoma
Phase 3
 
March 2015

Powered by ideaPoint, Inc.